Search
Organon & Co
OGNAdd to Watchlist
13.475USD
+0.025+0.19%
Close 06/24, 16:00（ET）Quotes delayed by 15 min
3.50BMarket Cap
14.27P/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Women’s Health
1.75B
28.19%
Cardiovascular
1.14B
18.26%
Non-Opioid Pain, Bone and Dermatology
987.00M
15.88%
Respiratory
842.00M
13.55%
Other
809.00M
13.01%
Biosimilars
691.00M
11.12%
By RegionUSD
Name
Revenue
Proportion
Europe and Canada
1.62B
26.03%
United States
1.60B
25.80%
Latin America, Middle East, Russia and Africa
1.07B
17.25%
Asia Pacific and Japan
1.00B
16.09%
China
829.00M
13.34%
Other
93.00M
1.50%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Women’s Health
1.75B
28.19%
Cardiovascular
1.14B
18.26%
Non-Opioid Pain, Bone and Dermatology
987.00M
15.88%
Respiratory
842.00M
13.55%
Other
809.00M
13.01%
Biosimilars
691.00M
11.12%
